중독성이 경감된 진통제
    1.
    发明公开
    중독성이 경감된 진통제 有权
    减少药物摄入的阳。

    公开(公告)号:KR1020070013639A

    公开(公告)日:2007-01-31

    申请号:KR1020050068094

    申请日:2005-07-26

    CPC classification number: A61K36/539 A61K36/66 A61K2236/331

    Abstract: Anodynes with reduced drug addiction are provided to improve use safety of anodynes while they maintains pain-alleviating effects by adding natural products capable of reducing drug addiction into anodynes. The anodynes with reduced drug addiction comprises morphine or nalbuphine as an anodyne, Scutellariae radix extract, betaine, and a pharmaceutically acceptable carrier, wherein the Scutellariae radix extract is prepared by heating Scutellariae radix in water and drying it, wherein the weight ratio of morphine or nalbuphine, Scutellariae radix extract and betaine is 1: 66: 44.

    Abstract translation: 提供降低药物成瘾性的痴呆症,以改善痴呆症的使用安全性,同时通过添加能够将药物成瘾减少为无效的天然产物来维持疼痛缓解作用。 具有降低药物成瘾性的痴呆症包括吗啡或纳布啡作为an ne,黄芩提取物,甜菜碱和药学上可接受的载体,其中黄芩提取物通过在水中加热黄芩并干燥而制备,其中吗啡或 纳布啡,黄芩提取物和甜菜碱为1:66:44。

    산마늘 추출물을 포함하는 동맥경화증 및고콜레스테롤혈증의 예방 및 치료용 조성물
    4.
    发明公开
    산마늘 추출물을 포함하는 동맥경화증 및고콜레스테롤혈증의 예방 및 치료용 조성물 有权
    用于预防和治疗包含ALLIUM VICTORIALIS提取物的肠粘膜炎和高胆固醇血症的组合物

    公开(公告)号:KR1020020050362A

    公开(公告)日:2002-06-27

    申请号:KR1020000079495

    申请日:2000-12-21

    Abstract: PURPOSE: A pharmaceutical composition containing an Allium victorialis var. platyphyllum extract having a therapeutic and preventing activity against arteriosclerosis as an effective component is provided which can be effectively used as a pharmaceutical component and an effective component of functional food for prevention and treatment of arteriosclerosis and hypercholesterolemia. CONSTITUTION: A dried Allium victorialis var. platyphyllum is ground to 20 to 100 mesh, mixed 2 to 5 times with ethanol and extracted at 15 to 50deg.C for 24 to 96 hr. The extract remarkably reduces the amount of cholesterol and lipid peroxide in blood and has an inhibition activity on cholesteryl ester transfer protein enzyme for transferring HDL cholesterol to arteriosclerosis-inducing low density lipoprotein cholesterol.

    Abstract translation: 目的:一种含有Allium v​​ictorialis var。 提供具有抗动脉硬化作用的治疗和预防活性的青蒿提取物作为有效成分,其可以有效地用作药物组分和用于预防和治疗动脉硬化和高胆固醇血症的功能食品的有效成分。 构成:干燥的Allium v​​ictorialis var。 将青蒿素研磨至20至100目,用乙醇混合2至5次,并在15至50℃下提取24至96小时。 提取物显着降低血液中胆固醇和脂质过氧化物的含量,对胆固醇酯转移蛋白酶具有抑制活性,用于将HDL胆固醇转移至动脉硬化诱导低密度脂蛋白胆固醇。

    오록실린 A를 함유하는 인지 기능 장애 관련 질환의 예방및 개선용 건강기능식품
    5.
    发明公开
    오록실린 A를 함유하는 인지 기능 장애 관련 질환의 예방및 개선용 건강기능식품 无效
    包含用于预防或改善认知功能障碍的甲酚A的健康护理食品组合物

    公开(公告)号:KR1020080008929A

    公开(公告)日:2008-01-24

    申请号:KR1020060114284

    申请日:2006-11-20

    Abstract: A health functional food comprising Oroxylin A is provided to improve spatial-perceptual ability of an animal group of which memory is decreased by scopolamine and carotid ligation, thereby being usefully used for treating and preventing cognitive impairment. A health functional food for preventing and improving Alzheimer's disease or cerebro vascular dementia comprises Oroxylin A and a sitologically acceptable food supplemental additive, wherein the Oroxylin A is isolated from an extract of Scutellaria baicalensis GEORGI. The food is in the form of powder, granule, tablet, capsule or drink.

    Abstract translation: 提供了包含奥昔木蛋白A的健康功能食品,以提高通过东莨菪碱和颈动脉结扎使记忆减少的动物组的空间感知能力,从而有效地用于治疗和预防认知障碍。 一种用于预防和改善阿尔茨海默病或脑血管性痴呆的健康功能食品包括奥昔木蛋白A和可食用的食品补充添加剂,其中,从黄芩黄芩提取物中分离出OroxylA A. 食物为粉末,颗粒,片剂,胶囊或饮料。

    스피노신을 포함하는 인지기능 장애 질환 예방 또는 치료용 약학조성물
    7.
    发明公开
    스피노신을 포함하는 인지기능 장애 질환 예방 또는 치료용 약학조성물 有权
    包含螺旋菌素用于预防和治疗认知障碍的药物组合物

    公开(公告)号:KR1020130060835A

    公开(公告)日:2013-06-10

    申请号:KR1020110127108

    申请日:2011-11-30

    Abstract: PURPOSE: A pharmaceutical composition containing spinosin or a spinosin-containing crude drug extract is provided to effectively improve memory and learning ability and to effectively prevent and treat cognitive disorders such as dementia and amnesia. CONSTITUTION: A composition for preventing or treating cognitive disorder contains spinosin. The composition also contains one or more extracts selected from a group consisting of Zizyphus jujuba Mill var. inermis, Zizyphus jujuba Mill var. hoonensis, Zizyphus jujuba Mill var. spinosa, Passiflora edulis flavicarpa, Cayaponia tayuya, Desmodium tortuosum, Wilbrandia ebracteata, Strophioblachia fimbricalyx, Clutia abyssinica, and Saccharopolyspora spinosa. The cognitive disorders are dementia or amnesia. A food composition for preventing or treating cognitive disorders contains spinosin. [Reference numerals] (AA) Delay time(seconds); (BB) In the middle of learning; (CC) In the middle of the present experiment; (DD) Control group 3; (EE) Control group 2; (FF) Medicine injected group 1; (GG) Medicine injected group 2; (HH) Medicine injected group 3; (II) Medicine injected group 4; (JJ) Control group 1

    Abstract translation: 目的:提供含有刺糖苷或含刺糖苷的生药提取物的药物组合物,有效提高记忆力和学习能力,有效预防和治疗认知障碍,如痴呆和遗忘症。 构成:用于预防或治疗认知障碍的组合物含有刺糖苷。 该组合物还含有一种或多种提取物,选自Zizyphus jujuba Mill var。 Z hus枣 枣树,枣树 菠萝,西番莲,洋葱,Cataaponia tayuya,枸杞,Wilbrandia ebracteata,Strophioblachia fimbricalyx,黑蛤和Saccharopolyspora spinosa。 认知障碍是痴呆或遗忘症。 用于预防或治疗认知障碍的食物组合物含有刺糖苷。 (附图标记)(AA)延迟时间(秒); (BB)在学习的中间; (CC)在本实验中期; (DD)对照组3; (EE)对照组2; (FF)药物注射组1; (GG)药物注射组2; (HH)药物注射组3; (二)药物注射组4; (JJ)对照组1

    마약중독 치료제
    8.
    发明公开
    마약중독 치료제 有权
    治疗药物用于治疗NARCOTICS

    公开(公告)号:KR1020070013640A

    公开(公告)日:2007-01-31

    申请号:KR1020050068095

    申请日:2005-07-26

    CPC classification number: A61K36/539 A61K2236/331 Y10S514/812

    Abstract: A therapeutic agent for narcotics addiction is provided to inhibit drug addiction of the narcotic anodynes, so that side effects of the narcotic anodynes are suppressed. The therapeutic agent for narcotics addiction comprises the Scutellariae radix extract and betaine as effective ingredients, and a pharmaceutically acceptable carrier, wherein the Scutellariae radix extract is prepared by extracting Scutellariae radix with hot water, and drying and pulverizing it; and the mixing ratio of Scutellariae radix extract and betaine is 4:6 to 7:3.

    Abstract translation: 提供麻醉药物成瘾的治疗剂以抑制麻醉药物成瘾,从而抑制麻醉药物的副作用。 毒瘾治疗剂包括黄芩提取物和甜菜碱作为有效成分,以及药学上可接受的载体,其中黄芩提取物通过用热水提取黄芩制备,并干燥并粉碎; 黄芩提取物和甜菜碱的混合比为4:6〜7:3。

    산마늘 추출물을 포함하는 동맥경화증 및고콜레스테롤혈증의 예방 및 치료용 조성물
    9.
    发明授权
    산마늘 추출물을 포함하는 동맥경화증 및고콜레스테롤혈증의 예방 및 치료용 조성물 有权
    마늘늘물물을함하하맥맥콜콜롤롤롤롤롤

    公开(公告)号:KR100387279B1

    公开(公告)日:2003-06-12

    申请号:KR1020000079495

    申请日:2000-12-21

    Abstract: PURPOSE: A pharmaceutical composition containing an Allium victorialis var. platyphyllum extract having a therapeutic and preventing activity against arteriosclerosis as an effective component is provided which can be effectively used as a pharmaceutical component and an effective component of functional food for prevention and treatment of arteriosclerosis and hypercholesterolemia. CONSTITUTION: A dried Allium victorialis var. platyphyllum is ground to 20 to 100 mesh, mixed 2 to 5 times with ethanol and extracted at 15 to 50deg.C for 24 to 96 hr. The extract remarkably reduces the amount of cholesterol and lipid peroxide in blood and has an inhibition activity on cholesteryl ester transfer protein enzyme for transferring HDL cholesterol to arteriosclerosis-inducing low density lipoprotein cholesterol.

    Abstract translation: 目的:一种含有葱属植物变种的药物组合物。 提供具有针对动脉硬化的治疗和预防活性的扁桃酚提取物作为有效成分,其可以有效地用作用于预防和治疗动脉硬化和高胆固醇血症的功能性食品的药物成分和有效成分。 组成:干韭菜var。 将Platyphyllum粉碎至20至100目,用乙醇混合2至5次,并在15至50℃提取24至96小时。 该提取物显着降低血液中胆固醇和脂质过氧化物的量,并且对胆固醇酯转移蛋白酶具有抑制活性,用于将HDL胆固醇转化为诱导动脉硬化的低密度脂蛋白胆固醇。

Patent Agency Ranking